Halifax-based Appili Therapeutics Inc. announces that they have received positive top-line results from a pivotal relative bioavailability study evaluating pharmacokinetics, safety, and palatability of ATI-1501 […]
Knight Therapeutics Inc., a leading Canadian specialty pharmaceutical company, announces that Health Canada has approved Probuphine (buprenorphine subdermal implant) for the management of opioid dependence […]
Mylan N.V. and Revance Therapeutics, Inc. announce a global collaboration and license agreement for the development and commercialization of a proposed biosimilar to BOTOX (onabotulinumtoxinA). BOTOX […]
MilliporeSigma introduces the Viresolve Barrier capsule filters to reduce the risk of bioreactor contamination. The filters are designed to remove viruses, mycoplasma and bacteria from cell culture media.